CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 2000, Vol. 72, No. 3, pp. 479-552

http://dx.doi.org/10.1351/pac200072030479

INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
SCIENTIFIC DIVISION
COMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS

CHEMISTRY AND HUMAN HEALTH DIVISION
CLINICAL CHEMISTRY SECTION
COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS

Properties and units in the clinical laboratory sciences. Part XII. Properties and units in clinical pharmacology and toxicology (Technical Report) (IFCC-IUPAC 1999)

Henrik Olesen1*, David Cowan2, Rafael De La Torre3, Ivan Bruunshuus1, Morten Rohde1 and Desmond Kenny4

1 Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
2 Drug Control Centre, London University, King's College, London, UK
3 IMIM, Dr. Aiguader 80, Barcelona, Spain
4 Dept. of Clinical Biochemistry, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland

Abstract:
The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name, or other. This causes difficulties in the transmission of requests and reports on properties for such substances in biological fluids to and from the clinical laboratories, and in the collating of this information from different sources.
The document comprises a list of properties of drugs in biological fluids for use in electronic transmission systems. Systematic names are presented together with a code value for each.

Projects

Additional info